We analyzed the recently published metastatic bladder cancer data set including 348 patients [30], grouped patients into molecular subtypes, and inferred miRNA activities in p53-like subtype (Supplementary Table S1, Supplementary Table S3, and Supplementary Figure S7). This evidence concerns the gene TP53 and urinary bladder carcinoma.